These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. PCI for stable coronary disease. De Servi S N Engl J Med; 2007 Jul; 357(4):416; author reply 417-8. PubMed ID: 17663027 [No Abstract] [Full Text] [Related]
23. Improving long-term outcomes of coronary intervention in patients with diabetes. Shen WF Chin Med J (Engl); 2009 Mar; 122(6):605-7. PubMed ID: 19323918 [No Abstract] [Full Text] [Related]
24. Chronic total occlusion: how do we get there from here? Meier B J Invasive Cardiol; 2001 Mar; 13(3):233-5; discussion 262-4. PubMed ID: 11231653 [No Abstract] [Full Text] [Related]
28. The simplest, the most difficult. Saito S Catheter Cardiovasc Interv; 2004 Oct; 63(2):220-1. PubMed ID: 15390242 [No Abstract] [Full Text] [Related]
29. Interview with Bernhard Meier, MD. Interview by Laurie Gustafson. Meier B J Invasive Cardiol; 2001 Mar; 13(3):184-92. PubMed ID: 11231643 [No Abstract] [Full Text] [Related]
30. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. Motovska Z; Kala P Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914 [TBL] [Abstract][Full Text] [Related]
31. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. Kandzari DE; Colombo A; Park SJ; Tommaso CL; Ellis SG; Guzman LA; Teirstein PS; Tamburino C; Ormiston J; Stone GW; Dangas GD; Popma JJ; Bass TA; J Am Coll Cardiol; 2009 Oct; 54(17):1576-88. PubMed ID: 19833256 [TBL] [Abstract][Full Text] [Related]
32. Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents. Yarkoni A; Brodsky A; Sabapathy R; Pershad A Indian Heart J; 2008; 60(3):195-9. PubMed ID: 19240306 [TBL] [Abstract][Full Text] [Related]
33. [Registries in cardiology. An essential instrument in health planning]. Fernández Palomeque C; Sevilla Pérez F Rev Esp Cardiol; 1993 Nov; 46(11):718-20. PubMed ID: 8290772 [No Abstract] [Full Text] [Related]
34. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry. Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S; J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343 [TBL] [Abstract][Full Text] [Related]
35. The world belongs to the brave. Chen SL; Kwan TW; Gao RL; Louvard Y; Nguyen T J Interv Cardiol; 2009 Apr; 22(2):97-8. PubMed ID: 19379465 [No Abstract] [Full Text] [Related]
36. Unique challenges of full metal jackets in the era of drug-eluting stents. Ho PC J Invasive Cardiol; 2009 Feb; 21(2):51-2. PubMed ID: 19182290 [No Abstract] [Full Text] [Related]